PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 72 filers reported holding PASSAGE BIO INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,545,000 | -47.0% | 1,235,869 | 0.0% | 2.89% | -42.7% |
| Q2 2022 | $2,917,000 | -23.9% | 1,235,869 | 0.0% | 5.04% | +8.3% |
| Q1 2022 | $3,831,000 | -51.2% | 1,235,869 | 0.0% | 4.65% | -32.7% |
| Q4 2021 | $7,848,000 | -33.6% | 1,235,869 | +4.2% | 6.91% | -30.7% |
| Q3 2021 | $11,811,000 | -10.6% | 1,185,869 | +18.9% | 9.97% | -9.5% |
| Q2 2021 | $13,207,000 | -13.2% | 997,506 | +14.5% | 11.02% | +6.2% |
| Q1 2021 | $15,224,000 | -1.1% | 870,948 | +44.6% | 10.38% | +37.8% |
| Q4 2020 | $15,399,000 | +95.7% | 602,248 | +0.4% | 7.53% | -4.4% |
| Q3 2020 | $7,868,000 | -55.5% | 600,127 | -7.3% | 7.88% | -45.2% |
| Q2 2020 | $17,699,000 | +204.3% | 647,609 | +75.3% | 14.38% | +915.8% |
| Q1 2020 | $5,817,000 | – | 369,332 | – | 1.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $1,648,629 | 2.12% |
| Versant Venture Management, LLC | 4,959,769 | $3,263,528 | 1.74% |
| BML Capital Management, LLC | 2,058,767 | $1,354,669 | 1.24% |
| Acuitas Investments, LLC | 418,161 | $275,150 | 0.16% |
| Orbimed Advisors | 10,124,576 | $6,661,971 | 0.14% |
| Lynx1 Capital Management LP | 190,124 | $125,102 | 0.08% |
| Frazier Life Sciences Management, L.P. | 1,758,219 | $1,156,908 | 0.08% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $263,200 | 0.04% |
| Marquette Asset Management, LLC | 86,050 | $56,621 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 506,600 | $333,343 | 0.01% |